Circulation: Deep vein thrombosis in patients hospitalized with Xinguan pneumonia in Wuhan.
-
Last Update: 2020-07-27
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The purpose !---- of this study is to investigate the incidence of deep vein thrombosis (DVT) in patients with new coronary pneumonia in patients who were hospitalized, including their incidence, risk factors, prognosis, and potential thrombosis prevention strategiesincluded 143 patients with new coronary pneumonia who were admitted to Wuhan Hospital from January 29 to February 29, 2020of the 143 patients with new coronary pneumonia (average 63 years old, 51.7% male), 66 had lower limb DVT (46.1%: 23 near end DVT, 43 cases of far-end DVT)patients with DVT had a higher age, lower oxygenation index, higher rate of cardiomyopathy, and poorer prognosis, including higher mortality (34.8 percent vs 11.7%) and lower discharge rate (48.5% vs 77.9%), compared to patients without DVTmultivariate analysis showed that only CURB-65 (consciousness status, urea, respiratory rate and blood pressure) scored 3-5 in the queue (advantage must be 6.122; P-0.031), Padua's predictive score of 4 points (4.016; P-0.04), D-D-D-dipolymer,1.0?g/mL (5.818; P-lt.0.014) and DVT are relatedcombined CURB-65 3-5 points, Padua predictive score of 4 and D-dipolymer sgt;1.0 sg/mL screening DVT sensitivity was 88.52 percent, specificity of 61.43 percentthe incidence of DVT was 34.0% (18) in patients with venous thrombosis prevention and 66.0% (35 cases) in patients with venous thrombosis in subgroups with a predictive score of 4 and 72 hours after admissionthe high incidence of DVT was high for patients with new coronary pneumonia in hospital and associated with poor prognosisthe prevention of venous thrombosis has a protective effect on patients with padua's predictive score of scoring more than 4 pointsthis study suggests that COVID-19 may be an additional risk factor for DVT in hospitalized patients.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.